Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy (HCM): The NHLBI HCM Registry.
3 institutional releases
Published in JAMA · View the paper (DOI)
A new model for predicting outcomes in hypertrophic cardiomyopathy has been developed by incorporating prospective data, including clinical history, imaging, and blood biomarker tests. This study found that integrating these methods into risk assessment can improve the prediction of fatal and nonfatal cardiac events.
Coverage from 3 institutions
- Researchers develop innovative model for risk assessment for hypertrophic cardiomyopathy NIH/Office of the Director · May 11, 2026 · first to report
- Heart scan and blood test improve risk prediction for inherited heart condition, major study finds University of Oxford · May 11, 2026
- Results of major heart study set to save lives, reduce unneeded heart implants University of Virginia Health System · May 13, 2026